The Effects of Combined Use of Recombinant Human Prourokinase Thrombolysis during PCI on Coronary Blood Flow and No-reflow in Patients with Acute Myocardial Infarction/FU Xiongwei， LI Longjun，MENG Zhaohui.//Medical Innovation of China，2025，22(17)： 029-034

    [Abstract]Objective： To explore the effect of intravascular injection of recombinant human urokinogen thrombolysis in patients with acute myocardial infarction during percutaneous coronary intervention (PCI) on improvingcoronaryblood flowand prognosis，and preventing theoccurrenceof no-reflow.Method：A total of100 patients withacute myocardial infarctionadmited to Yuxi Third People's Hospital from February 2O22 toFebruary 2024 were selected as the study subjects.The patients were divided into the control group and the experimental group by the random number table method， with 5O cases in each group.The control group received PCI treatment， theexperimental group underwent intravascular injection of Recombinant Human Urokinase for thrombolysis during PCI treatment.Coronary blood flow indicators [coronary flow reserve (CFR)，fractional flow reserve (FFR) ......